Fadi E Pulous1,2, Cynthia M Grimsley-Myers3, Shevali Kansal1, Andrew P Kowalczyk4,5, Brian G Petrich1. 1. From the Department of Pediatrics, Aflac Cancer and Blood Disorders Center (F.E.P., S.K., B.G.P.), Emory University School of Medicine, Atlanta, GA. 2. Cancer Biology Graduate Program (F.E.P.), Emory University School of Medicine, Atlanta, GA. 3. Department of Cell Biology (C.M.G.-M., A), Emory University School of Medicine, Atlanta, GA. 4. Winship Cancer Institute (A.P.K.), Emory University School of Medicine, Atlanta, GA. 5. Department of Dermatology (A.P.K.), Emory University School of Medicine, Atlanta, GA.
Abstract
RATIONALE: Endothelial barrier function depends on the proper localization and function of the adherens junction protein VE (vascular endothelial)-cadherin. Previous studies have suggested a functional relationship between integrin-mediated adhesion complexes and VE-cadherin yet the underlying molecular links are unclear. Binding of the cytoskeletal adaptor protein talin to the β-integrin cytoplasmic domain is a key final step in regulating the affinity of integrins for extracellular ligands (activation) but the role of integrin activation in VE-cadherin mediated endothelial barrier function is unknown. OBJECTIVE: To test the requirement of talin-dependent activation of β1 integrin in VE-cadherin organization and endothelial cell (EC) barrier function. METHODS AND RESULTS: EC-specific deletion of talin in adult mice resulted in impaired stability of intestinal microvascular blood vessels, hemorrhage, and death. Talin-deficient endothelium showed altered VE-cadherin organization at EC junctions in vivo. shRNA (short hairpin RNA)-mediated knockdown of talin1 expression in cultured ECs led to increased radial actin stress fibers, increased adherens junction width and increased endothelial monolayer permeability measured by electrical cell-substrate impedance sensing. Restoring β1-integrin activation in talin-deficient cells with a β1-integrin activating antibody normalized both VE-cadherin organization and EC barrier function. In addition, VE-cadherin organization was normalized by reexpression of talin or integrin activating talin head domain but not a talin head domain mutant that is selectively deficient in activating integrins. CONCLUSIONS: Talin-dependent activation of EC β1-integrin stabilizes VE-cadherin at endothelial junctions and promotes endothelial barrier function.
RATIONALE: Endothelial barrier function depends on the proper localization and function of the adherens junction protein VE (vascular endothelial)-cadherin. Previous studies have suggested a functional relationship between integrin-mediated adhesion complexes and VE-cadherin yet the underlying molecular links are unclear. Binding of the cytoskeletal adaptor protein talin to the β-integrin cytoplasmic domain is a key final step in regulating the affinity of integrins for extracellular ligands (activation) but the role of integrin activation in VE-cadherin mediated endothelial barrier function is unknown. OBJECTIVE: To test the requirement of talin-dependent activation of β1 integrin in VE-cadherin organization and endothelial cell (EC) barrier function. METHODS AND RESULTS: EC-specific deletion of talin in adult mice resulted in impaired stability of intestinal microvascular blood vessels, hemorrhage, and death. Talin-deficient endothelium showed altered VE-cadherin organization at EC junctions in vivo. shRNA (short hairpin RNA)-mediated knockdown of talin1 expression in cultured ECs led to increased radial actin stress fibers, increased adherens junction width and increased endothelial monolayer permeability measured by electrical cell-substrate impedance sensing. Restoring β1-integrin activation in talin-deficient cells with a β1-integrin activating antibody normalized both VE-cadherin organization and EC barrier function. In addition, VE-cadherin organization was normalized by reexpression of talin or integrin activating talin head domain but not a talin head domain mutant that is selectively deficient in activating integrins. CONCLUSIONS:Talin-dependent activation of EC β1-integrin stabilizes VE-cadherin at endothelial junctions and promotes endothelial barrier function.
Entities:
Keywords:
cadherins; cytoskeleton; endothelium; integrins; talin
Authors: Tadayuki Yago; Brian G Petrich; Nan Zhang; Zhenghui Liu; Bojing Shao; Mark H Ginsberg; Rodger P McEver Journal: J Exp Med Date: 2015-07-13 Impact factor: 14.307
Authors: Yvonne L Dorland; Tsveta S Malinova; Anne-Marieke D van Stalborch; Adam G Grieve; Daphne van Geemen; Nicolette S Jansen; Bart-Jan de Kreuk; Kalim Nawaz; Jeroen Kole; Dirk Geerts; René J P Musters; Johan de Rooij; Peter L Hordijk; Stephan Huveneers Journal: Nat Commun Date: 2016-07-15 Impact factor: 14.919
Authors: Bernhard Nieswandt; Markus Moser; Irina Pleines; David Varga-Szabo; Sue Monkley; David Critchley; Reinhard Fässler Journal: J Exp Med Date: 2007-12-17 Impact factor: 14.307
Authors: Jacob A VanderBurgh; Archit V Potharazu; Samantha C Schwager; Cynthia A Reinhart-King Journal: J Cell Sci Date: 2020-09-17 Impact factor: 5.285
Authors: Zaki Al-Yafeai; Brenna H Pearson; Jonette M Peretik; Elizabeth D Cockerham; Kaylea A Reeves; Umesh Bhattarai; Dongdong Wang; Brian G Petrich; A Wayne Orr Journal: Matrix Biol Date: 2020-11-04 Impact factor: 11.583
Authors: Giulia De Rossi; Maria Vähätupa; Enrico Cristante; Samantha Arokiasamy; Sidath E Liyanage; Ulrike May; Laura Pellinen; Hannele Uusitalo-Järvinen; James W Bainbridge; Tero A H Järvinen; James R Whiteford Journal: Arterioscler Thromb Vasc Biol Date: 2021-02-18 Impact factor: 10.514
Authors: Lilian Schimmel; Daisuke Fukuhara; Mark Richards; Yi Jin; Patricia Essebier; Emmanuelle Frampton; Marie Hedlund; Elisabetta Dejana; Lena Claesson-Welsh; Emma Gordon Journal: Development Date: 2020-04-06 Impact factor: 6.868
Authors: Fadi E Pulous; Jamie C Carnevale; Zaki Al-Yafeai; Brenna H Pearson; Jamie A G Hamilton; Curtis J Henry; A Wayne Orr; Brian G Petrich Journal: Angiogenesis Date: 2020-10-28 Impact factor: 10.658